Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response

By Bishop S.A.   Stokes C.R.   Gruffydd-Jones T.J.   Whiting C.V.   Humphries J.E.   Osborne R.   Papanastasopoulou M.   Harbour D.A.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1243-1250

Elsevier

Access to resources Recommend Favorite

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18

By Dunham S.P.   Flynn J.N.   Rigby M.A.   Macdonald J.   Bruce J.   Cannon C.   Golder M.C.   Hanlon L.   Harbour D.A.   Mackay N.A.   Spibey N.   Jarrett O.   Neil J.C.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1483-1496

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein

By Rigby M.A.   Mackay N.   Reid G.   Osborne R.   Neil J.C.   Jarrett O.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1095-1102

Elsevier

Access to resources Recommend Favorite

Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge

By Finerty S.   Stokes C.R.   Gruffydd-Jones T.J.   Hillman T.J.   Reeves N.A.   Whiting C.V.   Schaaper W.M.M.   Dalsgaard K.   Harbour D.A.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3254-3265

Elsevier

Access to resources Recommend Favorite

DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus

By Cuisinier A.M.   Mallet V.   Meyer A.   Caldora C.   Aubert A.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1085-1094

Elsevier

Access to resources Recommend Favorite